Cargando…

NLRP3 inflammasome: a novel link between lipoproteins and atherosclerosis

INTRODUCTION: Pattern recognition receptor-mediated signaling pathways have recently been elucidated to bridge the innate immune system and atherosclerosis. NLRP3 is a member of the NLR family. Upon activation, it initiates IL-1β and IL-18 processing, a key step in the inflammatory process of athero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wang Li, Hua, Li Gui, Qu, Peng, Yan, Wang Hong, Ming, Cui, Jun, Yuan Da, Yuan, Lou Da, Nan, Niu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016581/ https://www.ncbi.nlm.nih.gov/pubmed/27695484 http://dx.doi.org/10.5114/aoms.2016.61356

Ejemplares similares

Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
por: Jin, Ying, et al.
Publicado: (2019)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome
por: Bao, Chun-Hui, et al.
Publicado: (2019)

The Correlation between Increased Expressions of NLRP3 Inflammasome Components in Peripheral Blood Mono-Nuclear Cells and Plaque Vulnerability in Human Carotid Atherosclerosis
por: Xie, Wenli, et al.
Publicado: (2023)

Pyroptosis in NLRP3 inflammasome-related atherosclerosis
por: Zeng, Xiang, et al.
Publicado: (2022)

Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome
por: Fu, Yu, et al.
Publicado: (2022)

Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
por: Shahzad, Khurrum, et al.
Publicado: (2015)

Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice
por: Wang, Renqing, et al.
Publicado: (2017)

NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis
por: Liu, Yang, et al.
Publicado: (2020)

Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice
por: Zhao, Jingfei, et al.
Publicado: (2020)

Spotlight on NLRP3 Inflammasome: Role in Pathogenesis and Therapies of Atherosclerosis
por: Jiang, Chunteng, et al.
Publicado: (2021)

The crystal-induced activation of NLRP3 inflammasomes in atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
por: Paramel Varghese, Geena, et al.
Publicado: (2016)

P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation
por: PENG, KUANG, et al.
Publicado: (2015)

Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis
por: Wang, Yanan, et al.
Publicado: (2023)

Nur77 Deficiency Exacerbates Macrophage NLRP3 Inflammasome-Mediated Inflammation and Accelerates Atherosclerosis
por: Yuan, Ruosen, et al.
Publicado: (2022)

Myeloid β-Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
por: Wang, Fang, et al.
Publicado: (2018)

NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
por: Wan, Zhaofei, et al.
Publicado: (2019)

PI3K regulates the activation of NLRP3 inflammasome in atherosclerosis through part-dependent AKT signaling pathway
por: Liu, Zhenzhu, et al.
Publicado: (2021)

Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition
por: Ma, Sai, et al.
Publicado: (2018)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Snail-regulated exosomal microRNA-21 suppresses NLRP3 inflammasome activity to enhance cisplatin resistance
por: Cheng, Han-Ying, et al.
Publicado: (2022)

ER Stress Activates the NLRP3 Inflammasome: A Novel Mechanism of Atherosclerosis
por: Chen, Xinnong, et al.
Publicado: (2019)

Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation
por: Wen, Jiexia, et al.
Publicado: (2020)

NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis
por: Burger, Fabienne, et al.
Publicado: (2021)

NLRP3 and downstream cytokine expression elevated in the monocytes of patients with coronary artery disease
por: Wang, Lili, et al.
Publicado: (2014)

YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3
por: Wang, Dan, et al.
Publicado: (2021)

Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
por: Tanase, Daniela Maria, et al.
Publicado: (2023)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Effects and mechanisms of SGLT2 inhibitors on the NLRP3 inflammasome, with a focus on atherosclerosis
por: Yang, Liu, et al.
Publicado: (2022)

Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis
por: Jin, Ying, et al.
Publicado: (2022)

Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
por: Menu, P, et al.
Publicado: (2011)

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
por: Gregersen, Ida, et al.
Publicado: (2017)

Oridonin supplementation attenuates atherosclerosis via NLRP-3 inflammasome pathway suppression
por: Sultan, Ahmed, et al.
Publicado: (2023)

NFAT5 mediates hypertonic stress-induced atherosclerosis via activating NLRP3 inflammasome in endothelium
por: Ma, Pingping, et al.
Publicado: (2019)

Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity
por: Gao, Yuan, et al.
Publicado: (2021)

NLRP6 Inflammasome Ameliorates Brain Injury after Intracerebral Hemorrhage
por: Wang, Peng-Fei, et al.
Publicado: (2017)

Linking the sympathetic nervous system to the inflammasome: towards new therapeutics for atherosclerotic cardiovascular disease
por: Karakas, Mahir, et al.
Publicado: (2018)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome
por: Wang, Zhilei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o0t1fis5ggni0cktejtb21ot6c